Mark Tluszcz

Galenicum was founded in Barcelona in 2003 with the mission of improving the quality and affordability of pharmaceutical products. This purpose has remained at the core through all these years, while the company has grown to become a global ecosystem of several businesses within the pharmaceutical, food and nutritional supplement sectors. Galenicum covers the entire industry value chain and has commercial agreements in place that span more than forty countries worldwide. Galenicum continues its adventure to become a specialty global pharmaceutical company, bringing further innovation to products in the years to come.

Galenicum was founded in Barcelona in 2003 with the mission of improving the quality and affordability of pharmaceutical products. This purpose has remained at the core through all these years, while the company has grown to become a global ecosystem of several businesses within the pharmaceutical, food and nutritional supplement sectors. Galenicum covers the entire industry value chain and has commercial agreements in place that span more than forty countries worldwide. Galenicum continues its adventure to become a specialty global pharmaceutical company, bringing further innovation to products in the years to come.

Mangrove Capital Partners is a contrarian, bold but patient investment firm helping innovative entrepreneurs start and grow global, disruptive companies. We back a wide range of ventures across information technology with an emphasis on mobile, software, e-commerce and the mobility industry.